Blood cancers

Synergistic response with radiotherapy and immune therapy in Hodgkin lymphoma

Locally-directed radiotherapy has been reported by Victorian clinicians to boost the effect of systemic PD-1 inhibition in refractory classical Hodgkin lymphoma. A case study of a 24-year-old male with disease progression despite multiple therapies including nivolumab, appears to show an abscopal effect from radiation therapy to infradiaphragmatic sites. “Repeat PET/CT 6 weeks postradiotherapy demonstrated complete ...

Already a member?

Login to keep reading.

© 2021 the limbic